| Literature DB >> 2113888 |
R Sesso1, J M Eisenberg, C Stabile, S Draibe, H Ajzen, O Ramos.
Abstract
Cost-effectiveness analysis compared four treatments of end-stage renal disease in Brazil: continuous ambulatory peritoneal dialysis (CAPD), in-center hemodialysis (HD), cadaver donor transplantation (CD-Tx), and living related donor transplantation (LR-Tx). After 2 years, the costs per year of survival were CAPD, $12,134; HD, $10,065; CD-Tx, $6,978; and LR-Tx, $3,022. The HD cost was lower than CAPD partially because of the reuse of hemodialyzers in Brazil. Although less cost-effective, both dialysis treatments yielded more years of survival after 2 years. This analysis reveals a trade-off between cost per year of survival and years of survival.Entities:
Mesh：
Year: 1990 PMID： 2113888 DOI： 10.1017/s0266462300008965
Source DB: PubMed Journal: Int J Technol Assess Health Care ISSN： 0266-4623 Impact factor: 2.188